Position for Opiates: The Benefits to the Community, Cost Savings in the Long Run
This brief summarizes recent analysis examining the advantages and costs of material opiates therapy. An estimated $275 billion dollars yearly goes to investments in the U.S. on healthcare costs, lost work productivity, costs associated with drug-related criminal offenses, and on other costs relevant to drugs like opiates (Doweiko, 2011). The approximately $18 billion dollars invested yearly on substance therapies is funded primarily by public money, and studies to address the affordability of these therapies are growing. Issues arising include the extent to which therapy applications fall under the cover of healthcare benefits and the come back on these financial ...